PMPRB: Your chance to comment on 2 proposed amendments to PMPRB Guidelines
The Patented Medicine Prices Review Board (PMPRB) invites stakeholders to comment on two proposed consequential amendments to the new PMPRB Guidelines resulting from the decision to delay the coming-into-force date of the Regulations Amending the Patented Medicines Regulations (“Regulations”) a further six months, from January 1, 2021 to July 1, (more…)